IRS1 and metabolic dysfunction-associated steatotic liver disease: However, polymorphisms in IRS-1 can affect insulin receptor activity, and can significantly predispose biopsy-proven NAFLD individuals to worse disease severity (Dongiovanni et al., 2010).